📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Adgero Biopharm

1.1 - Company Overview

Adgero Biopharm Logo

Adgero Biopharm

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapies leveraging a proprietary late-stage photodynamic therapy platform for serious oncology indications. Pipeline includes REM-001, a second-generation PDT photosensitizer for cutaneous metastatic breast cancer and other serious cutaneous oncology indications; IFx-2.0, a personalized cancer vaccine intended for use with Keytruda in advanced Merkel cell carcinoma; and bi-functional ADCs targeting MDSCs.

Products and services

  • REM-001: Second-generation photodynamic therapy (PDT) photosensitizer used to treat cutaneous metastatic breast cancer and other serious cutaneous oncology indications, demonstrating high complete response rates at evaluable tumor sites
  • Bi-Functional Antibody Drug Conjugates (ADCs): First-in-class targeted assemblies that bind MDSCs to diminish immunosuppression in the tumor microenvironment, aiming to prevent T-cell exhaustion and resistance to therapies
  • IFx-2.0: Personalized cancer vaccine constructing tumor cells to express a bacterial protein, priming innate immune responses, intended for combination with Keytruda to treat advanced Merkel cell carcinoma

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Adgero Biopharm

Ficontec Logo

Ficontec

HQ: Germany Website
  • Description: Provider of automated micro-assembly and testing solutions for the photonics industry, independent of device material and application. Modular systems scalable from early device development to high-volume manufacturing. Products include ASSEMBLYLINE for die-level assembly, CUSTOMLINE for flexible assembly, TESTLINE for die-level testing, WAFER TESTLINE for wafer-level testing, and STACKLINE for stacking semiconductor laser diode bars.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ficontec company profile →
Norlase Logo

Norlase

HQ: Denmark Website
  • Description: Provider of ophthalmic laser solutions for retina and glaucoma treatment. Products include ECHO, a battery-powered portable pattern laser that attaches to compatible slit lamps and uses MEMS miniaturization; LEAF, an ultra-compact green laser photocoagulator for slit-lamp mounting; and LION, a battery-powered laser indirect ophthalmoscope with integrated green laser for portable retinal treatment, wireless operation, and voice control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Norlase company profile →
Teknovus Logo

Teknovus

HQ: United States Website
  • Description: Provider of access chips and embedded software for broadband access networks in the FTTx market, offering Ethernet passive optical network (EPON) integrated chips for central office and customer premises applications, EPON customer premises equipment (ONU), and TDM transport chips.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Teknovus company profile →
Precision OT Logo

Precision OT

HQ: United States Website
  • Description: Provider of optical transceivers and related active/passive optical components, offering 100G optical transceivers and QSFP28 direct attach and active optical cables for transport, data center, and metro networks. Delivers OpenPath, an end-to-end PON access solution, and conducts R&D in integrated silicon photonics, signal processing, and software-defined networking.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precision OT company profile →
Freedom Photonics Logo

Freedom Photonics

HQ: United States Website
  • Description: Provider of photonics components, offering high-power diode and DFB lasers and semiconductor optical amplifiers across 770-1550 nm. Products include 2.5 W diffraction-limited 1550 nm lasers and amplifiers, 870-1000 nm 1 W single spatial mode lasers, and O-band/C-band high-power DFB lasers in 14-pin butterfly packages. Applications include free-space optical communication, sensing, LIDAR, and resonant end-pumping of Nd- and Yb-doped solid-state and fiber lasers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Freedom Photonics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Adgero Biopharm

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Adgero Biopharm

2.2 - Growth funds investing in similar companies to Adgero Biopharm

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Adgero Biopharm

4.2 - Public trading comparable groups for Adgero Biopharm

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Adgero Biopharm

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Adgero Biopharm

What does Adgero Biopharm do?

Adgero Biopharm is a provider of biopharmaceutical therapies leveraging a proprietary late-stage photodynamic therapy platform for serious oncology indications. Pipeline includes REM-001, a second-generation PDT photosensitizer for cutaneous metastatic breast cancer and other serious cutaneous oncology indications; IFx-2.0, a personalized cancer vaccine intended for use with Keytruda in advanced Merkel cell carcinoma; and bi-functional ADCs targeting MDSCs.

Who are Adgero Biopharm's competitors?

Adgero Biopharm's competitors and similar companies include Ficontec, Norlase, Teknovus, Precision OT, and Freedom Photonics.

Where is Adgero Biopharm headquartered?

Adgero Biopharm is headquartered in United States.

How many employees does Adgero Biopharm have?

Adgero Biopharm has 1,000 employees 🔒.

When was Adgero Biopharm founded?

Adgero Biopharm was founded in 2010 🔒.

What sector and industry vertical is Adgero Biopharm in?

Adgero Biopharm is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adgero Biopharm

Who are the top strategic acquirers in Adgero Biopharm's sector and industry

Top strategic M&A buyers and acquirers in Adgero Biopharm's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adgero Biopharm?

Top strategic M&A buyers groups and sectors for Adgero Biopharm include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adgero Biopharm's sector and industry vertical

Which are the top PE firms investing in Adgero Biopharm's sector and industry vertical?

Top PE firms investing in Adgero Biopharm's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adgero Biopharm's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adgero Biopharm's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adgero Biopharm's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adgero Biopharm include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adgero Biopharm's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adgero Biopharm?

The key public trading comparables and valuation benchmarks for Adgero Biopharm include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adgero Biopharm for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adgero Biopharm with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adgero Biopharm's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adgero Biopharm with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adgero Biopharm's' sector and industry vertical?

Access recent funding rounds and capital raises in Adgero Biopharm's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Adgero Biopharm